IOC

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Università Politecnica delle Marche

Conditions

Cholecystitis; GallstoneImmune System DiseasesLymphoproliferative DisordersPeripheral T-cell Lymphomas

Phase 2

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

RecruitingNCT03922724

National Cancer Institute (NCI)Immune System Diseases, Lymphoproliferative Disorders, Peripheral T-cell Lymphomas

Start: 2019-04-18End: 2030-10-31Target: 330Updated: 2026-03-30

Unknown Phase

Safety of Laparoscopic ChOlecystectomy Performed by Trainee Surgeons With Different CHolangiographic Techniques

Università Politecnica delle MarcheCholecystitis; Gallstone

Start: 2021-06-01End: 2021-12-31Target: 1500Updated: 2021-10-08

Related Papers

Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT

Blood2024-11-05

Safety of laparoscopic cholecystectomy performed by trainee surgeons with different cholangiographic techniques (SCOTCH): a prospective non-randomized trial on the impact of fluorescent cholangiography during laparoscopic cholecystectomy performed by trainees.

2023-12-225 citations